Global healthcare

May 19, 2022

FDA Expands Indication for Smallpox Treatment

May 19, 2022 – Tpoxx® (tecovirimat – SIGA Technologies) has received an expanded smallpox treatment indication, as well as FDA approval of a new dosage formulation
May 12, 2022

FDA Approves New Oral Medication for ALS

May 12, 2022 – Radicava ORS® (edaravone – Mitsubishi Tanabe Pharma America), has received FDA approval to treat amyotrophic lateral sclerosis (ALS) in adults.